ImmuCell Corporation Proceeds from Sale of Other Productive Assets
ImmuCell Corporation (ICCC) reported Proceeds from Sale of Other Productive Assets of $15 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherProductiveAssets · last filed 2023-05-11
- ImmuCell Corporation proceeds from sale of other productive assets for the quarter ending 2023-03-31 was $15.00, a 99.86% decline year-over-year.
- ImmuCell Corporation proceeds from sale of other productive assets for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation proceeds from sale of other productive assets for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation proceeds from sale of other productive assets for the quarter ending 2022-06-30 was $0.00.
- ImmuCell Corporation proceeds from sale of other productive assets for fiscal 2022 was $11.00K, a 28.06% decline from fiscal 2021.
- ImmuCell Corporation proceeds from sale of other productive assets for fiscal 2021 was $15.29K, a 66.47% decline from fiscal 2020.
- ImmuCell Corporation proceeds from sale of other productive assets for fiscal 2020 was $45.60K, a 89.87% decline from fiscal 2019.
- ImmuCell Corporation proceeds from sale of other productive assets for fiscal 2019 was $450.00K.
| Period end | Proceeds from Sale of Other Productive Assets 3 month | Proceeds from Sale of Other Productive Assets 6 month | Proceeds from Sale of Other Productive Assets 9 month | Proceeds from Sale of Other Productive Assets 12 month |
|---|---|---|---|---|
| 2023-03-31 | $15.00 10-Q · filed 2023-05-11 | $15.00 derived: sum of 2 quarters · filed 2023-05-11 | $15.00 derived: sum of 3 quarters · filed 2023-05-11 | $15.00 derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $11.00K 10-K · filed 2023-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $0.00 derived: sum of 2 quarters · filed 2022-11-21 | $11.00K 10-Q · filed 2022-11-21 | $12.31K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-21 | $11.00K 10-Q/A · filed 2022-11-21 | $12.31K derived: sum of 3 quarters · filed 2023-05-11 | $16.29K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | $11.00K 10-Q · filed 2023-05-11 | $12.31K derived: sum of 2 quarters · filed 2023-05-11 | $16.29K derived: sum of 3 quarters · filed 2023-05-11 | $16.29K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.31K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $5.29K derived: sum of 2 quarters · filed 2023-03-29 | $5.29K derived: sum of 3 quarters · filed 2023-03-29 | $15.29K 10-K · filed 2023-03-29 |
| 2021-09-30 | $3.98K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $3.98K derived: sum of 2 quarters · filed 2022-11-21 | $13.97K 10-Q · filed 2022-11-21 | $58.98K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | $10.00K 10-Q/A · filed 2022-11-21 | $55.00K derived: sum of 3 quarters · filed 2022-11-21 | $55.00K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $10.00K 10-Q/A · filed 2022-11-21 | $55.00K derived: sum of 2 quarters · filed 2022-11-21 | $55.00K derived: sum of 3 quarters · filed 2022-11-21 | $55.00K derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $45.00K derived: sum of 2 quarters · filed 2022-03-30 | $45.00K derived: sum of 3 quarters · filed 2022-03-30 | $45.60K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $600.00 10-Q · filed 2021-11-15 | $200.60K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $600.00 10-Q · filed 2021-08-12 | $200.60K derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | $600.00 10-Q · filed 2021-05-13 | $200.60K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $450.00K 10-K · filed 2021-03-30 | ||
| 2019-09-30 | $250.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |